Form 4: Eli Lilly Executive Eric Dozier Reports Acquisition of Shares and Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Eric Dozier, EVP, HR & Diversity at Eli Lilly & Co, reports acquiring common stock and restricted stock units.

Summary

  • Eric Dozier, an executive at Eli Lilly & Co, filed a Form 4 detailing changes in beneficial ownership.
  • On February 10, 2025, Dozier acquired 919.525 shares of common stock at $868.88 per share.
  • Dozier also acquired 2,858 restricted stock units, each representing a contingent right to receive one share of Eli Lilly common stock, exercisable on February 1, 2026, expiring on February 1, 2026.
  • Following these transactions, Dozier directly owns 8,962.122 shares of common stock and indirectly owns 314.3 shares through a 401(k).
  • Dozier also directly owns 2,858 restricted stock units.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing, so the sentiment is neutral.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and their potential alignment with shareholder interests.

Stakeholder Impact

  • The acquisition of shares by an executive can be viewed positively by shareholders as it aligns management's interests with theirs.

Key Dates

DateDescription
02/10/2025Date of transaction for common stock and restricted stock units acquisition
02/01/2026Exercisable and expiration date for restricted stock units
02/12/2025Date of signature for the report

Keywords

Form 4, Beneficial Ownership, Eric Dozier, Eli Lilly, LLY, Restricted Stock Units, Common Stock, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.